Neuromyelitis optica (NMO) and related NMO spectrum disorders are debilitating neuroinflammatory diseases for which no cure is available. In a retrospective analysis of clinical records of 52 patients with these disorders, Kageyama et al. evaluated the efficacy of various immunosuppressants. Cyclosporine A and azathioprine were found to enable reduced dose of coadministered prednisone, and significantly decreased relapse rates.
ORIGINAL RESEARCH PAPER
Kageyama, T. et al. Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica. J. Neurol. doi:10.1007/s00415-012-6692-2
Rights and permissions
About this article
Cite this article
Cyclosporine A and azathioprine are effective adjunctive treatments for neuromyelitis optica. Nat Rev Neurol 8, 659 (2012). https://doi.org/10.1038/nrneurol.2012.235
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2012.235